[fcb5af]: / literature / by_gene_clean / NOTCH2.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 34494161 10.1007/s00428-021-03186-3 2022 Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin. NOTCH2
2 34632572 10.1111/bjh.17858 2022 Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma. NOTCH2
3 35236331 10.1186/s12885-022-09237-5 2022 Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma. NOTCH2
4 35317330 10.14740/wjon1436 2022 Non-GCB Diffuse Large B-Cell Lymphoma With an Atypical Disease Course: A Case Report and Clinical Exome Analysis. NOTCH2
5 35834399 10.1097/PAS.0000000000001932 2022 Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features. NOTCH2
6 35964234 10.1093/ajcp/aqac087 2022 Histiocytic Sarcoma With CCND1 Gene Rearrangement Clonally Related and Transdifferentiated From Mantle Cell Lymphoma. NOTCH2
7 32273478 10.3324/haematol.2020.251579 2021 Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma. NOTCH2
8 33311649 10.1038/s41379-020-00720-7 2021 Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice. NOTCH2
9 34039950 10.1038/s41408-021-00493-5 2021 Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing. NOTCH2
10 34204385 10.3390/cancers13123032 2021 Cell-Free Total Nucleic Acid-Based Genotyping of Aggressive Lymphoma: Comprehensive Analysis of Gene Fusions and Nucleotide Variants by Next-Generation Sequencing. NOTCH2
11 34378195 10.1111/bjh.17765 2021 Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohort. NOTCH2
12 35008340 10.3390/cancers14010176 2021 Recent Advances in the Genetic of MALT Lymphomas. NOTCH2
13 31894255 10.3892/ijmm.2019.4418 2020 Precision medicine for human cancers with Notch signaling dysregulation (Review). NOTCH2
14 32239385 10.1007/s11523-020-00710-4 2020 Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib. NOTCH2
15 32239765 10.1002/ajh.25796 2020 Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients. NOTCH2
16 32585984 10.3390/cancers12061669 2020 Discovery of Novel Recurrent Mutations and Clinically Meaningful Subgroups in Nodal Marginal Zone Lymphoma. NOTCH2
17 32598477 10.1182/bloodadvances.2019001350 2020 Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis. NOTCH2
18 32871937 10.1097/MD.0000000000021938 2020 Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report. NOTCH2
19 33211828 10.1182/bloodadvances.2020002944 2020 Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease. NOTCH2
20 30802265 10.1371/journal.pone.0212813 2019 Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma. NOTCH2
21 30963600 10.1002/ajh.25487 2019 Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. NOTCH2
22 31320741 10.1038/s41598-019-46906-1 2019 Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma. NOTCH2
23 31378966 10.1002/ajh.25600 2019 Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network. NOTCH2
24 31395597 10.1101/mcs.a004259 2019 Divergent clonal evolution of a common precursor to mantle cell lymphoma and classic Hodgkin lymphoma. NOTCH2
25 29641966 10.1056/NEJMoa1801445 2018 Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma. NOTCH2
26 29735551 10.1158/0008-5472.CAN-17-4004 2018 Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses. NOTCH2
27 29989027 10.18632/oncotarget.25601 2018 New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes. NOTCH2
28 27347751 10.1080/10428194.2016.1196813 2017 Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies. NOTCH2
29 26426381 10.1097/PAS.0000000000000523 2016 NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease. NOTCH2
30 27121112 10.3109/10428194.2016.1173212 2016 Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets. NOTCH2
31 27248180 10.18632/oncotarget.9678 2016 The genetic landscape of dural marginal zone lymphomas. NOTCH2
32 27335277 10.1182/blood-2016-02-696757 2016 The genetics of nodal marginal zone lymphoma. NOTCH2
33 27566587 10.18632/oncotarget.11548 2016 Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas. NOTCH2
34 25428260 10.1038/leu.2014.330 2015 KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype. NOTCH2
35 25779943 10.1158/1078-0432.CCR-14-2759 2015 Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing. NOTCH2
36 24689848 10.1111/cas.12408 2014 Disease-specific mutations in mature lymphoid neoplasms: recent advances. NOTCH2
37 24349473 10.1371/journal.pone.0083244 2013 Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma. NOTCH2
38 22891273 10.1084/jem.20120904 2012 The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. NOTCH2
39 19001083 10.1182/blood-2008-03-147967 2009 Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases. NOTCH2